Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Tonix Licenses Via-the-nose Treatment Technology From Inserm
2 Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)
3 Improving immunotherapies for blood cancers: real-time exploration in the tumor
4 New 'UK variant' of Covid predicted to be dominant in France by March
5 Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Receives License From Inserm To Use Oxytocin Based Therapeutics To Treat Prader Willi Syndrome And Prevent Obesity In Children
6 In vivo imaging reveals how anti-CD20 antibodies guide the immune system to attack tumors
7 New data on COVID-19 patients with diabetes show that one in five die within
8 Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients
9 French experts predict spike in Covid hospitalisations in March
10 1 in 5 Diabetes Patients Hospitalized With COVID-19 Die in 28 Days
11 Inserm selects Expert System's artificial intelligence to support COVID-19 research
12 The French National Institute of Health and Medical Research (Inserm) Selects Expert System's Artificial Intelligence to Support COVID-19 Research
13 Paris, Marseille to hold experimental concerts to test Covid transmission
14 Cytovia, Inserm Partnering on NK-based Immunotherapies for Myeloma
15 French researchers set for HIV vaccine trials using dendritic cells
16 Informatica Helps The Institut National de la Santé et de la Recherche Médicale (Inserm) to Advance Research with AI-Driven Data Management
17 Ebola in Guinea: ALIMA prepares to respond to the country's first outbreak since 2016
18 Informatica deal with French health research agency highlights role of data in pandemic fight
19 Expediting innovation in the rare disease domain
20 CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
21 Michel Sadelain Awarded 2019 Inserm International Prize
22 Can herbicides cause breast cancer? Purdue and INSERM scientists discover a piece to the puzzle.
23 French doctor apologises for suggesting COVID-19 treatment be tested in Africa
24 Type 1 interferon deficiency: Biomarker of patients at risk of severe COVID
25 [Full text] Experience and Perceptions of Changes in the Living Environment by Old | RMHP
26 Inserm Moves to Electronic Lab with Adoption of Labguru
27 INSERM leads in patent applications, reports European Patent Office
28 Korian Continues Its Growth With Resilient 2020 Results and Enters the High End UK Care Home Market
29 France launches AI voice assistant to help coronavirus patients
30 Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
31 Linda Fried Honored with 2016 Inserm International Prize | Columbia Public Health
32 French doctor apologizes for comments on testing a COVID-19 vaccine in Africa, prompting outrage on social media
33 20,000 volunteer for Covid-19 vaccine trials in France
34 Human textiles to repair blood vessels
35 Embattled French health-agency chief withdraws leadership bid
36 Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection
37 AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases
38 Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes
39 Risk of coronavirus importation in Africa
40 TxCell Signs in-Licensing Global Agreement with Inserm Transfert for Novel Population of Regulatory T Cells
41 Telix Pharmaceuticals Enters Partnership with INSERM and ARRONAX
42 ILiAD Biotechnologies, Inserm and Inserm Transfert SA, and Institut Pasteur de Lille Enter Scientific Collaboration and Worldwide License Agreements for Vaccine Technology
43 Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
44 Is it possible to 'knit' replacement blood vessels? | Medical Design and Outsourcing
45 The Helmholtz Association and Inserm create 2 joint research laboratories in France
46 In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, | COPD
47 AstraZeneca undertakes kidney disease collaborations with University of Michigan and Inserm
48 Prospects of new treatments for diabetes through metabolic products of the intestinal flora
49 Is physical activity always good for the heart?
50 Owkin launches global patient data sharing network for training AIs
51 PhD student Dr Nathan Peiffer-Smadja receives prestigious grant award
52 REFILE-BRIEF-Dassault Systemes and Inserm announce joint agreement
53 NIDA Director Honored By French Government With Top Science Award for Addiction Research
54 HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases
55 Production of iPS cells: Discovery of the fifth element
56 French doctor: Clear link between blood type and Covid risk
57 Multitasking Splits the Brain
58 Key Patent Granted For AAVLife's Gene-Therapy Program to Treat Cardiomyopathy in Friedreich's Ataxia
59 Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
60 Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea. | MSF
61 CLOVES Syndrome: Remarkable improvement in the health of 19 patients medical first
62 Epigenetic alteration of a vitamin B12 processing gene shines new light on our understanding of rare diseases
63 Follow the Money: Big Investments In CRISPR, Cell Therapies, Health Data Management
64 First in vivo proof-of-concept in Steinert's myotonic dystrophy